The following table sets forth a disaggregation of the Company’s net sales by geographic region and segment and product group for the years ended December 31, 2019 and 2018.

	Year Ended December 31,
	2019		2018
Net sales by geographic region (1)
North America:
Fluoroproducts	$	1,104	$	1,143
Chemical Solutions		313		341
Titanium Technologies		727		894
Total North America		2,144		2,378
Asia Pacific:
Fluoroproducts		673		675
Chemical Solutions		61		81
Titanium Technologies		809		964
Total Asia Pacific		1,543		1,720
Europe, the Middle East, and Africa:
Fluoroproducts		666		825
Chemical Solutions		23		18
Titanium Technologies		474		842
Total Europe, the Middle East, and Africa		1,163		1,685
Latin America (2):
Fluoroproducts		205		219
Chemical Solutions		136		162
Titanium Technologies		335		474
Total Latin America		676		855
Total net sales	$	5,526	$	6,638

Net sales by segment and product group
Fluoroproducts:
Fluorochemicals	$	1,318	$	1,497
Fluoropolymers		1,330		1,365
Chemical Solutions:
Mining solutions		268		289
Performance chemicals and intermediates		265		313
Titanium Technologies:
Titanium dioxide and other minerals		2,345		3,174
Total net sales	$	5,526	$	6,638

Substantially all of the Company’s net sales are derived from goods and services transferred at a point in time.

The Company’s assets and liabilities from contracts with customers constitute accounts receivable - trade, deferred revenue, and customer rebates. An amount for accounts receivable - trade is recorded when the right to consideration under a contract becomes unconditional. An amount for deferred revenue is recorded when consideration is received prior to the conclusion that a contract exists, or when a customer transfers consideration prior to the Company satisfying its performance obligations under a contract. Customer rebates represent an expected refund liability to a customer based on a contract. In contracts with customers where a rebate is offered, it is generally applied retroactively based on the achievement of a certain sales threshold. As revenue is recognized, the Company estimates whether or not the sales threshold will be achieved to determine the amount of variable consideration to include in the transaction price.

The following table sets forth the Company’s contract balances from contracts with customers at December 31, 2019 and 2018.

The Company’s deferred revenue balances at December 31, 2019 and 2018 were not significant. Additionally, changes in the Company’s deferred revenue balances resulting from additions for advance payments and deductions for amounts recognized in net sales during the years ended December 31, 2019 and 2018, were not significant. For the years ended December 31, 2019 and 2018, the amount of revenue recognized from performance obligations satisfied in prior periods (e.g., due to changes in transaction price) was not significant.

There were no other contract asset balances or capitalized costs associated with obtaining or fulfilling customer contracts at December 31, 2019 and 2018.

Certain of the Company’s MSA or other arrangements contain take-or-pay clauses, whereby customers are required to purchase a fixed minimum quantity of product during a specified period, or pay the Company for such orders, even if not requested by the customer. The Company considers these take-or-pay clauses to be an enforceable contract, and as such, the legally-enforceable minimum amounts under such an arrangement are considered to be outstanding performance obligations on contracts with an original expected duration greater than one year. At December 31, 2019 and 2018, Chemours had $83 and $119 of remaining performance obligations, respectively. The Company expects to recognize approximately 69% of its remaining performance obligations as revenue in 2020, an approximate additional 16% in 2021, and the balance thereafter. The Company applies the practical expedient and does not include remaining performance obligations that have original expected durations of one year or less, or amounts for variable consideration allocated to wholly-unsatisfied performance obligations or wholly-unsatisfied distinct goods that form part of a single performance obligation, if any. Amounts for contract renewals that are not yet exercised by December 31, 2019 and 2018 are also excluded.